In an interview conducted at the 2024 American Society of Hematology Annual Meeting in San Diego, California, Prithviraj Bose, MD, The University of Texas MD Anderson Cancer Center,…
Systemic mastocytosis, a rare blood disorder, affects the entire body. There are many challenges associated with living with this systemic mastocytosis that are centered around reducing the frequency…
NEW YORK (Reuters Health) – The 2010 Update of the practice parameter on the diagnosis and management of anaphylaxis emphasizes education and self-administration of epinephrine for patients with…
NEW YORK (Reuters Health) – There appears to be no increase or decrease in mortality among arthritis patients treated with anti-tumor necrosis factor agents, when compared to standard…
NEW YORK (Reuters Health) – Patients with rhinoconjunctivitis due to tree pollen allergy suffer fewer symptoms after 18 months’ treatment with a depigmented-polymerized pollen extract, according to a…
NEW YORK (Reuters Health) – When kids have asthma symptoms on moderate doses of inhaled corticosteroids (ICS), adding a long-acting beta-agonist (LABA) achieves the same effect as doubling…
NEW YORK (Reuters Health) ñ Allergen-specific immune therapy allows children with allergic asthma to reduce their steroid use, a randomized trial has shown. Based on the results, immunotherapy…
NEW YORK (Reuters Health) – Children and adolescents with juvenile idiopathic arthritis who have a clinical response to treatment with the biologic agent abatacept experience a significant improvement…
NEW YORK (Reuters Health) –There’s no reliable evidence to support or refute the use of glucocorticoids for treating anaphylaxis, despite recommendations found in several guidelines, according to the…
NEW YORK (Reuters Health) – Treating rheumatoid arthritis aggressively in the early stages, aiming for remission, produces good outcomes that are maintained for at least a decade- this…
NEW YORK (Reuters Health) – In HIV-infected adults with low plasma zinc levels, supplementation at nutritional levels for 18 months prevents immune failure during antiretroviral therapy and reduces…
NEW YORK (Reuters Health) – In mice, treating primary respiratory syncytial virus (RSV) with the cysteinyl leukotriene 1 receptor antagonist montelukast reduces airway hyperresponsiveness and inflammation after RSV…
